Home > Financial Ratios > PANACEA BIOTEC

PANACEA BIOTEC
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for PANACEA BIOTEC
Please provide your vote to see the results

PANACEA BIOTEC Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -3.53-20.68-1.9011.704.68

What is the latest Core EBITDA Margin ratio of PANACEA BIOTEC ?

The latest Core EBITDA Margin ratio of PANACEA BIOTEC is -3.53 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar2024-3.53
Mar2023-20.68
Mar2022-1.90
Mar202111.70
Mar20204.68

How is Core EBITDA Margin of PANACEA BIOTEC Trending?

Years Core EBITDA Margin % Change
Mar2024 -3.53
Negative
Mar2023 -20.68
Negative
Mar2022 -1.9
Negative
Mar2021 11.7
150.00
Mar2020 4.68 -

Other Financial Ratios of PANACEA BIOTEC


Compare Core EBITDA Margin ratio of peers of PANACEA BIOTEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PANACEA BIOTEC ₹2,504.4 Cr -0.8% 0.1% 206.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,702.0 Cr -3.3% -4.6% -7.9% Stock Analytics
DIVIS LABORATORIES ₹156,908.0 Cr -9% -13.6% 24% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,896.0 Cr -1.1% 7% 8.2% Stock Analytics
CIPLA ₹119,988.0 Cr -2% 0.6% -4% Stock Analytics
DR REDDYS LABORATORIES ₹101,122.0 Cr -1.1% -3.8% -13.3% Stock Analytics


PANACEA BIOTEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PANACEA BIOTEC

-0.8%

0.1%

206.6%

SENSEX

-0.9%

-4.4%

1.6%


You may also like the below Video Courses